Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2010
08/18/2010EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010CN1993352B Piperazine derivatives with CCR3 inhibiting activity
08/18/2010CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors
08/18/2010CN101809015A Salts of a CGRP antagonist, method for producing the same and use thereof as drugs
08/18/2010CN101809014A Method for producing pyrazol-3-yl-benzamide derivative
08/18/2010CN101809013A herbicide triazolylpyridine ketones
08/18/2010CN101809012A Spiro substituted compounds as angiogenesis inhibitors
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101808999A Quinoline derivatives as 5HT5A receptor antagonists
08/18/2010CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/18/2010CN101808994A Compounds and methods for kinase modulation, and indications therefor
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808990A Piperidine derivatives as modulators of chemokine receptor activity
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101805327A Rabeprazole sodium compound and novel preparation method thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101250166B Thiadiazoles formamide derivative as well as synthesis and uses thereof
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777049 Serotonin receptor antagonists
08/17/2010US7777044 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1′-binaphthalene-2,2′diol
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7776900 gamma--aminobutyric acid A (GABAA) receptor modulators such as 1-[3-(Pyridin-2-ylmethoxymethyl)-phenyl]-1H-benzoimidazole-5-carboxylic acid ethyl ester, useful in the treatment of central nervous system diseases and disorders; anxiolytic agents; side effect reduction
08/17/2010US7776891 antagonists of very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis; N-{N-[(3-Cyanobenzene)sulfonyl]-4(R)-[3,3-difluoropiperidinyl]-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl)amino]-(L)-phenylalanine ethyl ester
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/17/2010US7776883 Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776872 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/17/2010US7776862 Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
08/17/2010US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants
08/17/2010US7776182 8-Oxyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione; antiyellowing agents for lignin
08/17/2010CA2605854C Novel pyridine derivative and pyrimidine derivative (3)
08/17/2010CA2545092C Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2407208C Process for producing optically active sulfoxide derivative
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/17/2010CA2377236C Pyrazole derivative, production process thereof, and pest control agent containing the same as active ingredient
08/17/2010CA2370412C Pharmaceutical compounds
08/17/2010CA2325471C Piperididinyl and n-amidinopiperidinyl derivatives
08/12/2010WO2010091209A1 Pyridine compounds as subtype selective modulators of alpha2b and/or alpha 2c adrenergic receptors
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010090875A1 Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/12/2010WO2010090347A1 Dihydroquinolinone derivatives
08/12/2010WO2010090344A1 Hydrazide compound and use of the same in pest control
08/12/2010WO2010090299A1 A novel cyanopyrimidine derivative
08/12/2010WO2010090290A1 Aminopyrazine derivative and medicine
08/12/2010WO2010090198A1 Process for preparing 1-(4-piperidinyl)benzimidazolone derivatives
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089327A2 Indole derivatives as anticancer agents
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010089119A1 Heterocyclic derivatives as m-glu5 antagonists
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010067085A3 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
08/12/2010WO2010042758A3 Oxazole-pyridazine-oxazole alpha-helix mimetic
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
08/12/2010US20100204479 Crystalline forms of dexlansoprazole
08/12/2010US20100204478 Improved process for amophous rabeprazole sodium
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204470 method for salt preparation
08/12/2010US20100204282 Reverse indoles as 5-lipoxygenase-activating protein (FLAP) inhibitors
08/12/2010US20100204280 Cinnamoyl inhibitors of transglutaminase
08/12/2010US20100204279 Therapeutic Salt Compositions and Methods
08/12/2010US20100204276 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/2010US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204272 Compounds which have activity at M1 receptor and their uses in medicine
08/12/2010US20100204260 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204246 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer
08/12/2010US20100204245 Amino-pyridines As Inhibitors Of Beta-secretase
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204228 Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
08/12/2010US20100204227 Isoindoline compounds and methods of their use
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204216 PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-beta PROTEIN ACCUMULATION
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100203645 Novel zwitterionic dyes for labeling in proteomic and other biological anaylses
08/12/2010US20100203613 Aminopyridine Dimer Compounds, Compositions and Related Methods for Neuronal Nitric Oxide Synthase Inhibition
08/12/2010US20100200054 Compound for organic photoelectric device and organic photoelectric device including the same
08/12/2010US20100199443 Yello anionic disazo dyes
08/12/2010CA2751695A1 Aminopyrazine derivatives and medicines
08/12/2010CA2751651A1 Pyridine compounds as subtype selective modulators of alpha2b and/or alpha 2c adrenergic receptors
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1080